<Techniclone International> said it has entered a joint venture with Seeds of Tomorrow to apply its electrogene process to developing new or improved plant varieties. The process, which has a patent pending, was developed originally for use in human cancer. The joint venture will address genetic transformation of cotton and tomatoes. The company said it is also negotiating such ventures with several other plant companies. 